Trending News

JOURNAVX(suzetrigine): FDA Approves  New Treatment for Acute Pain

JOURNAVX(suzetrigine): FDA Approves New Treatment for Acute Pain

What is it prescribed for? JOURNAVX is prescribed for the treatment of moderate to severe short-term (acute) pain in adults​. It was approved on January 30th 2025 What is the name of the drug and what does it do? The brand name is JOURNAVX (pronounced "JOR-na-vix"), and the generic name is suzetrigine. JOURNAVX is used to relieve acute pain that ranges from moderate...

Malignant Gliomas: What You Should Know About the Brain Tumor Making Headlines

Malignant Gliomas: What You Should Know About the Brain Tumor Making Headlines

A malignant glioma is a tumor that begins in the brain’s glial cells. These cells normally support and protect nerve cells, but when they become cancerous, they can grow into surrounding brain tissue. Because they spread into nearby healthy tissue, malignant gliomas are often difficult to remove completely with surgery. Although they remain challenging to treat, advances in imaging, surgery, radiation, chemotherapy, and newer targeted therapies are improving care for many patients.

ZAYNICH™: A New FDA-Approved Treatment for Patients With Advanced Cancer

ZAYNICH™: A New FDA-Approved Treatment for Patients With Advanced Cancer

What is it prescribed for? ZAYNICH is a medication used to treat adults with advanced cancer that has progressed after prior treatments. It is typically used in patients whose cancer has specific features identified through testing and who have limited remaining treatment options. Advanced cancers can become resistant to standard therapies over time, making them...